Previous pregnancy is a favourable prognostic factor in women with localised cutaneous melanoma

References

• Stensheim H, Moller B, van Dijk T, Fossa SD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: A registry-based cohort study. J Clin Oncol 2009;27:45–51.
   PubMed Web of Science ®Google Scholar
• Weisz B, Schiff E, Lishner M. Cancer in pregnancy: Maternal and fetal implications. Hum Reprod Update 2001;7:384–93.
   PubMed Web of Science ®Google Scholar
• Lacal PM, Failla CM, Pagani E, Odorisio T, Schietroma C, Falcinelli S, . Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor. J Invest Dermatol 2000;115:1000–7.
   PubMed Web of Science ®Google Scholar
• Reintgen DS, McCarty KS Jr, Vollmer R, Cox E, Seigler HF. Malignant melanoma and pregnancy. Cancer 1985;55:1340–4.
   PubMed Web of Science ®Google Scholar
• Lens M, Rosdahl I, Ahlbom A, Farahmand BY, Synnerstad I, Boeryd B, . Effect of pregnancy on survival in woman with cutaneous malignant melanoma. J Clin Oncol 2004;22:4369–75.
   PubMedGoogle Scholar
• Lens M, Bataille V. Melanoma in relation to reproductive and hormonal factors in women: Current review on controversial issues. Cancer Causes Control 2008;19:437–42.
   PubMedGoogle Scholar
• Tang JY, Spaunhurst KM, Chlebowski RT, Wactawski-Wende J, Keiser E, Thomas F, . Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: Women's health initiative randomized trials. J Natl Cancer Inst 2011;103:1469–75.
   PubMedGoogle Scholar
• O'Meara AT, Cress R, Xing G, Danielsen B, Smith LH. Malignant melanoma in pregnancy. A population-based evaluation. Cancer 2005;103:1217–26.
   PubMed Web of Science ®Google Scholar
• Stensheim H, Cvancarova M, Moller B, Fossa SD. Pregnancy after adolescent and adult cancer: A population-based matched cohort study. Int J Cancer 2011;129: 1225–36.
   PubMed Web of Science ®Google Scholar
• Oduncu FS, Kimmig R, Hepp H, Emmerich B. Cancer in pregnancy: Maternal-fetal conflict. J Cancer Res Clin Oncol 2003;129:133–46.
   PubMed Web of Science ®Google Scholar
• Alexander A, Samlowski W, Grossman D, Bruggers CS, Harris RM, Zone JJ, . Metastatic melanoma in pregnancy: Risk of transplacental metastases in the infant. J Clin Oncol 2003;21:2179–86.
   PubMed Web of Science ®Google Scholar
• Pages C, Robert C, Thomas L, Maubec E, Sassolas B, Granel-Brocard F, . Management and outcome of metastatic melanoma during pregnancy. Br J Dermatol 2010;162:274–81.
   PubMed Web of Science ®Google Scholar
• Brady MS, Noce NS. Pregnancy is not detrimental to the melanoma patient with localized disease. J Clin Aesthetic Dermatol 2010;3:22–8.
   PubMedGoogle Scholar
• Daryanani D, Plukker JT, De Hullu JA, Kuiper H, Nap RE, Hoekstra HJ. Pregnancy and early stage melanoma. Cancer 2003;97:2248–53.
   PubMed Web of Science ®Google Scholar
• Hersey P, Morgan G, Stone DE, McCarthy WH, Milton GW. Previous pregnancy as a protective factor against death from melanoma. Lancet 1977;1:451–2.
   PubMedGoogle Scholar
• Kaae J, Andersen A, Boyd HA, Wohlfahrt J, Melbye M. Reproductive history and cutaneous malignant melanoma: A comparison between women and men. Am J Epidemiol 2007;165:1265–70.
   PubMedGoogle Scholar
• Lea CS, Holly EA, Hartge B, Lee JS, Guerry D, Elder DE, . Reproductive risk factor for cutaneous melanoma in women: A case-control study. Am J Epidemiol 2007;165: 505–13.
   PubMedGoogle Scholar
• Nading MA, Nanney LB, Boyd AS, Ellis DL. Estrogen receptor beta expression in nevi during pregnancy. Exp Dermatol 2008;17:489–97.
   PubMedGoogle Scholar
• Zhao D, Dahlman-Wright K, Gustafsson JA. Estrogen receptor β: An overview and update. Nucl Recept Signal 2008;6e003.
   PubMedGoogle Scholar
• Schmidt AN, Nanney LB, Boyd AS, King LE Jr, Ellis DL. Oestrogen receptor-β expression in melanocytic lesions. Exp Dermatol 2006;15:971–80.
   PubMedGoogle Scholar
• de Giorgi V, Sestini S, Gori A, Mazzotta C, Grazzini M, Rossarini S, . Polymorphisms of estrogen receptors: Risk factors for invasive melanoma – a prospective study. Oncology 2011;80:232–7.
   PubMedGoogle Scholar
• Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the million women study: Cohort study. BMJ 2007;335:1134–45.
   PubMed Web of Science ®Google Scholar
• Menzies AM, Visintin L, Chatfield MD, Carlino MS, Howle JR, Scolyer RA, . BRAF mutation by age-decade and body mass index in metastatic melanoma. J Clin Oncol 2011;29(Suppl; abstr 8507).
   PubMedGoogle Scholar
• Joosse A, de Vries E, Eckel R, Nijsten T, Eggermont AM, Hölzer D, . Gender differences in melanoma survival: Female patients have a decreased risk of metastasis. J Invest Dermatol 2011;131:719–26.
   PubMed Web of Science ®Google Scholar
• Balch CM, Gershenwald JE, Soong S-J, Thompson JF, Atkins MB, Byrd DR . Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009;27:6199–206.
   PubMed Web of Science ®Google Scholar